Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Cavassini

Showing results (11-20 of 447) with videos related to

Pageof 45
Sort By:
Revue Medicale Suisse|January 15, 2025
[HIV: what's new in 2024]Emeline Gauthiez, Micol Pallanza, Matthias Cavassini, et al.
Revue Medicale Suisse|July 4, 2017
[Emergency medicine and prevention : a contradiction in terms ? Observations based on HIV screening]Olivier Hugli, Luca Tagliabue, Matthias Cavassini, et al.
International Journal of Clinical Pharmacy|April 25, 2012
Characteristics of HIV patients referred to a medication adherence program in SwitzerlandIsabelle Krummenacher, Matthias Cavassini, Olivier Bugnon, et al.
Journal of Virology|December 15, 2015
In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase InhibitorsRiddhima Banga, Francesco Andrea Procopio, Matthias Cavassini, et al.
AIDS Care|January 29, 2011
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoringIsabelle Krummenacher, Matthias Cavassini, Olivier Bugnon, et al.
International Journal of Clinical Pharmacy|July 31, 2016
Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV careAurélie Rotzinger, Matthias Cavassini, Olivier Bugnon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2021
A 31-Year-Old Patient Living With Human Immunodeficiency Virus With Thyroiditis and Multiple Intrathoracic LesionsParaskevas Filippidis, Jean-Luc Barras, Matthias Cavassini, et al.
Antiviral Therapy|February 4, 2012
Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infectionErika Castro, Patricia Recordon-Pinson, Matthias Cavassini, et al.
Revue Medicale Suisse|January 14, 2021
[HIV in the time of COVID-19 : the meeting between two pandemics]Olivier Nawej Tshikung, Hélène Buvelot, Alexandra Calmy, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
Pageof 45

Showing results (11-20 of 447) with videos related to

Sort By:
Pageof 45
Revue Medicale Suisse|January 15, 2025
[HIV: what's new in 2024]Emeline Gauthiez, Micol Pallanza, Matthias Cavassini, et al.
Revue Medicale Suisse|July 4, 2017
[Emergency medicine and prevention : a contradiction in terms ? Observations based on HIV screening]Olivier Hugli, Luca Tagliabue, Matthias Cavassini, et al.
International Journal of Clinical Pharmacy|April 25, 2012
Characteristics of HIV patients referred to a medication adherence program in SwitzerlandIsabelle Krummenacher, Matthias Cavassini, Olivier Bugnon, et al.
Journal of Virology|December 15, 2015
In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase InhibitorsRiddhima Banga, Francesco Andrea Procopio, Matthias Cavassini, et al.
AIDS Care|January 29, 2011
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoringIsabelle Krummenacher, Matthias Cavassini, Olivier Bugnon, et al.
International Journal of Clinical Pharmacy|July 31, 2016
Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV careAurélie Rotzinger, Matthias Cavassini, Olivier Bugnon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2021
A 31-Year-Old Patient Living With Human Immunodeficiency Virus With Thyroiditis and Multiple Intrathoracic LesionsParaskevas Filippidis, Jean-Luc Barras, Matthias Cavassini, et al.
Antiviral Therapy|February 4, 2012
Multiclass primary antiretroviral drug resistance in a patient presenting HIV-1/2 dual infectionErika Castro, Patricia Recordon-Pinson, Matthias Cavassini, et al.
Revue Medicale Suisse|January 14, 2021
[HIV in the time of COVID-19 : the meeting between two pandemics]Olivier Nawej Tshikung, Hélène Buvelot, Alexandra Calmy, et al.
Revue Medicale Suisse|February 1, 2023
[News in HIV infection, long-acting injectable treatments]Olivier Nawej Tshikung, Olivier Segeral, Matthias Cavassini, et al.
Pageof 45